• Skip to main content
  • Skip to secondary menu
  • Skip to primary sidebar
  • Skip to secondary sidebar
  • Skip to footer

  • COVID-19
  • Opinion
  • Health IT
    • Behavioral Health
    • Care Coordination
    • EMR/EHR
    • Interoperability
    • Patient Engagement
    • Population Health Management
    • Revenue Cycle Management
    • Social Determinants of Health
  • Digital Health
    • Artificial Intelligence
    • Blockchain
    • Mobile Health
    • Precision Medicine
    • Telehealth
    • Wearables
  • Startups
  • M&A
  • Value-based Care
    • Accountable Care (ACOs)
    • Medicare Advantage
  • Life Sciences
  • Research

FemTech: Samsung Adds Menstrual Cycle Tracking Capabilities to Galaxy Watch5

by Jasmine Pennic 02/14/2023 Leave a Comment

FemTech: Samsung Adds Menstrual Cycle Tracking Capabilities to Galaxy Watch5

What You Should Know:

– Samsung Galaxy Watch5 users will soon be able to access temperature-based menstrual cycle tracking through the Cycle Tracking feature. This new capability was developed in partnership with Natural Cycles, a women’s health company and app maker, and marks the first time Natural Cycles’ algorithm has been adapted for a smartwatch.

– The partnership combines Natural Cycles’ fertility technology with Samsung’s BioActive Sensor to give users more detailed insights into their menstrual cycle by tracking temperature changes and other key indicators to determine each user’s unique fertility status.

Cycle Tracking Feature

The Cycle Tracking feature has also been registered with the Food and Drug Administration (FDA) and complies with CE Marking requirements. The proprietary algorithm uses body temperature and other key fertility indicators to determine each user’s unique fertility status. Natural Cycles leverages its technology and algorithm to power the Cycle Tracking feature available on the Samsung Health app with the Galaxy Watch5 series.

Leveraging Samsung’s BioActive Sensor, the new infrared temperature sensor enables users to get a more detailed overview by tracking skin temperature changes as well as their menstrual cycle. The temperature sensor uses infrared technology for more accurate readings, even if there is a temperature change in their surroundings or they move while sleeping. With all data encrypted and stored on the user’s device itself, it give users more control of their health data and better peace of mind.

“As a company that’s grounded in science and technology, we are excited to partner with Samsung to deliver a premium experience that pushes women’s health forward,” said Dr. Raoul Scherwitzl, co-founder and co-CEO of Natural Cycles. “The Natural Cycles app has helped millions of women around the world take control of their fertility and this partnership will allow Samsung to leverage our fertility technology to offer temperature-based cycle tracking through a smartwatch for the first time.”

Tagged With: Artificial Intelligence, FDA, Femtech, Samsung, Smartwatch

Get in-depth healthcare technology analysis and commentary delivered straight to your email weekly

Reader Interactions

Primary Sidebar

Subscribe to HIT Consultant

Latest insightful articles delivered straight to your inbox weekly.

Submit a Tip or Pitch

Most Popular

Survey: Clinician Burnout Is A Public Health Crisis Demanding Urgent Action

17 Execs Share How Health IT Can Address Clinician Burnout, Staffing, & Capacity

Q/A: Dr. Johnson Talks Racial Disparities in Breast Cancer Care

Q/A: Dr. Johnson Talks Racial Disparities in Breast Cancer Care

Northwell Health Extends Contract with Allscripts Sunrise Platform Through 2027

Northwell to Deploy Epic Enterprise EHR Platform Across System

Sanofi Cuts Price of Lantus Insulin by 78% & Caps Out of Pocket Costs at $35 for All Patients

Sanofi Cuts Price of Lantus Insulin by 78% & Caps Out of Pocket Costs at $35 for All Patients

Pfizer Acquires Seagen for $43B to Tackle Cancer

Pfizer Acquires Seagen for $43B to Tackle Cancer

5 Key Trends Driving Purchasing Decisions in Healthcare IT

5 Key Trends Driving Purchasing Decisions in Healthcare IT

Sanofi to Acquire Diabetes Therapy Maker Provention Bio for $2.9B

Sanofi to Acquire Diabetes Therapy Maker Provention Bio for $2.9B

Dr. Arti Masturzo

Q/A: Dr. Masturzo Talks Addressing Food Insecurity with Patients

Transcarent Acquires 98point6 AI-Powered Virtual Care Platform and Care Business

Transcarent Acquires 98point6 AI-Powered Virtual Care Platform and Care Business

Eli Lilly Cuts Insulin Prices by 70%, Caps Patient Costs at $35 Per Month

Eli Lilly Cuts Insulin Prices by 70%, Caps Patient Costs at $35 Per Month

Secondary Sidebar

Footer

Company

  • About Us
  • Advertise with Us
  • Reprints and Permissions
  • 2023 Editorial Calendar
  • Submit An Op-Ed
  • Contact
  • Subscribe

Editorial Coverage

  • Opinion
  • Health IT
    • Care Coordination
    • EMR/EHR
    • Interoperability
    • Population Health Management
    • Revenue Cycle Management
  • Digital Health
    • Artificial Intelligence
    • Blockchain Tech
    • Precision Medicine
    • Telehealth
    • Wearables
  • Startups
  • Value-Based Care
    • Accountable Care
    • Medicare Advantage

Connect

Subscribe to HIT Consultant Media

Latest insightful articles delivered straight to your inbox weekly

Copyright © 2023. HIT Consultant Media. All Rights Reserved. Privacy Policy |